Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer immunotherapy
deals
gilead sciences
johnson & johnson
startups
abbvie
aducanumab
affordable care act
alzheimer's disease
avexis
What
nash
5
×
drug
news
roundup
bio
disease
approved
biogen’s
companies
fatty
known
liver
new
according
aducanumab
akcea
alzheimer’s
amyloid
angst
approval
bagged
billions
biogen
biopharmaceutical
biotech
brammer
cases
centers
cigarettes
control
convo
data
deaths
digital
earlier
effects
electronic
epidemic
failure
failures
Language
unset
Current search:
nash
×
" nonalcoholic steatohepatitis "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug